These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 30410668)

  • 41. Senescence-associated IL-6 and IL-8 cytokines induce a self- and cross-reinforced senescence/inflammatory milieu strengthening tumorigenic capabilities in the MCF-7 breast cancer cell line.
    Ortiz-Montero P; Londoño-Vallejo A; Vernot JP
    Cell Commun Signal; 2017 May; 15(1):17. PubMed ID: 28472950
    [TBL] [Abstract][Full Text] [Related]  

  • 42. p53 functional deficiency in human colon cancer cells promotes fibroblast-mediated angiogenesis and tumor growth.
    Hayashi Y; Tsujii M; Kodama T; Akasaka T; Kondo J; Hikita H; Inoue T; Tsujii Y; Maekawa A; Yoshii S; Shinzaki S; Watabe K; Tomita Y; Inoue M; Tatsumi T; Iijima H; Takehara T
    Carcinogenesis; 2016 Oct; 37(10):972-984. PubMed ID: 27520561
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Elevated expression of TGF-beta1 in head and neck cancer-associated fibroblasts.
    Rosenthal E; McCrory A; Talbert M; Young G; Murphy-Ullrich J; Gladson C
    Mol Carcinog; 2004 Jun; 40(2):116-21. PubMed ID: 15170816
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The crosstalk between breast carcinoma-associated fibroblasts and cancer cells promotes RhoA-dependent invasion
    Daubriac J; Han S; Grahovac J; Smith E; Hosein A; Buchanan M; Basik M; Boucher Y
    Oncotarget; 2018 Feb; 9(12):10375-10387. PubMed ID: 29535813
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Specific inhibition of fibroblast activation protein (FAP)-alpha prevents tumor progression in vitro.
    Teichgräber V; Monasterio C; Chaitanya K; Boger R; Gordon K; Dieterle T; Jäger D; Bauer S
    Adv Med Sci; 2015 Sep; 60(2):264-72. PubMed ID: 26057860
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Selection of p53-Deficient Stromal Cells in the Tumor Microenvironment.
    Farmaki E; Chatzistamou I; Bourlis P; Santoukou E; Trimis G; Papavassiliou AG; Kiaris H
    Genes Cancer; 2012 Sep; 3(9-10):592-8. PubMed ID: 23486847
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Corrigendum to "Dicer reprograms stromal fibroblasts to a pro-inflammatory and tumor-promoting phenotype in ovarian cancer" [Cancer Lett. 2018 Feb 28; 415:20-29].
    Yang Z; Jin P; Xu S; Zhang T; Yang X; Li X; Wei X; Sun C; Chen G; Ma D; Gao Q
    Cancer Lett; 2018 Nov; 436():159-160. PubMed ID: 30131187
    [No Abstract]   [Full Text] [Related]  

  • 48. Corrigendum to "Dicer reprograms stromal fibroblasts to a pro-inflammatory and tumor-promoting phenotype in ovarian cancer" [Cancer Lett 415 (20-29)].
    Yang Z; Jin P; Xu S; Zhang T; Yang X; Li X; Wei X; Sun C; Chen G; Ma D; Gao Q
    Cancer Lett; 2020 Jan; 469():527-528. PubMed ID: 31740089
    [No Abstract]   [Full Text] [Related]  

  • 49. Regulation of eukaryotic protein kinases by Pin1, a peptidyl-prolyl isomerase.
    Chen XR; Igumenova TI
    Adv Biol Regul; 2023 Jan; 87():100938. PubMed ID: 36496344
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Interleukin-6 released by oral lichen planus myofibroblasts promotes angiogenesis.
    Xu XH; Liu Y; Feng L; Yang YS; Liu SG; Guo W; Zhou HX; Li ZQ; Zhang L; Meng WX
    Exp Ther Med; 2021 Apr; 21(4):291. PubMed ID: 33717234
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clinical and functional significance of tumor/stromal ATR expression in breast cancer patients.
    Al-Ansari MM; Al-Saif M; Arafah M; Eldali AM; Tulbah A; Al-Tweigeri T; Semlali A; Khabar KS; Aboussekhra A
    Breast Cancer Res; 2020 May; 22(1):49. PubMed ID: 32414408
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Let-7b inhibits cancer-promoting effects of breast cancer-associated fibroblasts through IL-8 repression.
    Al-Harbi B; Hendrayani SF; Silva G; Aboussekhra A
    Oncotarget; 2018 Apr; 9(25):17825-17838. PubMed ID: 29707149
    [TBL] [Abstract][Full Text] [Related]  

  • 53. ATR suppresses the pro-tumorigenic functions of breast stromal fibroblasts.
    Al-Ansari MM; Aboussekhra A
    Oncotarget; 2018 Oct; 9(78):34681-34690. PubMed ID: 30410668
    [TBL] [Abstract][Full Text] [Related]  

  • 54. CHEK2 represses breast stromal fibroblasts and their paracrine tumor-promoting effects through suppressing SDF-1 and IL-6.
    Al-Rakan MA; Hendrayani SF; Aboussekhra A
    BMC Cancer; 2016 Aug; 16():575. PubMed ID: 27484185
    [TBL] [Abstract][Full Text] [Related]  

  • 55. p16(INK4A) represses the paracrine tumor-promoting effects of breast stromal fibroblasts.
    Al-Ansari MM; Hendrayani SF; Shehata AI; Aboussekhra A
    Oncogene; 2013 May; 32(18):2356-64. PubMed ID: 22751126
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Decorin (DCN) Downregulation Activates Breast Stromal Fibroblasts and Promotes Their Pro-Carcinogenic Effects through the IL-6/STAT3/AUF1 Signaling.
    Aljagthmi WA; Alasmari MA; Daghestani MH; Al-Kharashi LA; Al-Mohanna FH; Aboussekhra A
    Cells; 2024 Apr; 13(8):. PubMed ID: 38667295
    [TBL] [Abstract][Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.